Ishikawa Toru, Ohashi Kazuki, Kodama Erina, Kobayashi Takamasa, Azumi Motoi, Nozawa Yujiro, Iwanaga Akito, Sano Tomoe, Honma Terasu
Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Department of Nursing, Sapporo University of Health Sciences, Hokkaido, Japan.
Gastro Hep Adv. 2022 Apr 5;1(3):431-436. doi: 10.1016/j.gastha.2022.02.017. eCollection 2022.
The prognosis of acute liver failure (ALF) treated with conservative therapy is extremely poor. Histologic diagnosis at the time ALF occurs provides important clues for determining the prognosis, including indications for liver transplant. Transjugular liver biopsy (TJLB), which helps clarify the pathology of ALF, may be an effective clinical parameter that contributes to prognosis prediction, including indications for liver transplant.
In this prospective study, 79 patients who underwent TJLB with ALF were enrolled between May 2002 and March 2021. The relationships between prognosis and the extent of tissue necrosis on TJLB specimens, serum parameters related to the cause, and clinical parameters were investigated.
Model for end-stage liver disease-sodium, hepatic encephalopathy predicting, total bilirubin, hepatocyte growth factor, ammonia, coma rate, and histologic diagnosis were identified as prognostic factors on univariate analysis. Histologically, 13 of 16 patients with massive hepatic necrosis died or had a liver transplant. On multivariate analysis, the only prognostic factor was massive hepatic necrosis. There were no treatment-related complications, and TJLB was technically successful in all patients.
In diagnosing the cause of ALF and understanding its pathology, TJLB contributes to predicting the prognosis of ALF based on histologic findings together with liver function tests and imaging findings, and it is an important diagnostic technique for determining diagnostic and treatment eligibility, including indications for liver transplant. When determining the best timing for patient selection and liver transplant, the finding of massive hepatic necrosis on TJLB specimens at the time ALF occurred was the most important prognostic factor.
采用保守治疗的急性肝衰竭(ALF)预后极差。ALF发生时的组织学诊断为判断预后提供了重要线索,包括肝移植指征。经颈静脉肝活检(TJLB)有助于明确ALF的病理情况,可能是有助于预后预测(包括肝移植指征)的有效临床参数。
在这项前瞻性研究中,纳入了2002年5月至2021年3月期间接受TJLB的79例ALF患者。研究了预后与TJLB标本上组织坏死程度、与病因相关的血清参数以及临床参数之间的关系。
单因素分析确定终末期肝病模型-钠、肝性脑病预测、总胆红素、肝细胞生长因子、氨、昏迷率和组织学诊断为预后因素。组织学上,16例发生大块肝坏死的患者中有13例死亡或接受了肝移植。多因素分析显示,唯一的预后因素是大块肝坏死。未出现与治疗相关的并发症,所有患者的TJLB技术操作均成功。
在诊断ALF病因并了解其病理过程中,TJLB有助于根据组织学检查结果以及肝功能检查和影像学检查结果预测ALF的预后,是确定诊断和治疗资格(包括肝移植指征)的重要诊断技术。在确定患者选择和肝移植的最佳时机时,ALF发生时TJLB标本上出现大块肝坏死是最重要的预后因素。